| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP synthase inhibitory factor subunit 1 | 0.769 | 0.346 | 1.0E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2007 | 2014 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1993 | 2008 | ||||||||
|
caspase 7 | 0.581 | 0.654 | 5.4E-05 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
stanniocalcin 2 | 0.573 | 0.692 | 0.27 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1967 | 1967 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
retinoid X receptor alpha | 0.543 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
Purkinje cell protein 4 | 0.682 | 0.423 | 2.2E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
F-box protein 10 | 0.861 | 0.154 | 2.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 |